Home / Dermatologicals / Terbinafine
ATC D01BA02 · Antifungals for Systemic Use · updated 4 Nov 2026
Terbinafine shortage
As of 4 Nov 2026, Terbinafine has a reported shortage in 5 of the 16 countries we track (Canada, Italy, Belgium, Czechia, Japan), covering 26 products from 18 companies.
Is there a Terbinafine shortage?
Yes. As of 4 Nov 2026, Terbinafine is reported short in 5 of the 16 countries we track: Canada, Italy, Belgium, Czechia, Japan. The earliest expected return is 13 Nov 2026 (Belgium). 15 of 26 affected products have no return date. New since 5 Oct 2026: Belgium.
How the shortage spread
All cross-border shortagesCountries in the order the shortage started there (earliest start date of a product still short). First reported in Canada on 15 Sep 2016; most recently in Italy on 31 Aug 2026.
Not on the official list in: United States, Germany, France, Spain, Ireland, Austria, Switzerland, Norway, Sweden, New Zealand, Australia.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Teva TEVA · NYSE / TASE, Novartis NOVN · SIX Swiss, Aurobindo AUROPHARMA · NSE, Viatris VTRS · Nasdaq, Sandoz SDZ · SIX Swiss, Sawai 4887 · Tokyo, Sun Pharma SUNPHARMA · NSE, Towa (Pensa) 4553 · Tokyo
Affected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | JAMP-TERBINAFINE (30) | JAMP PHARMA CORPORATION | 15 Sep 2016 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-TERBINAFINE (28) | TEVA CANADA LIMITED | 18 Oct 2016 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-TERBINAFINE (100) | JAMP PHARMA CORPORATION | 15 Sep 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TERBINAFINE (100) | SANIS HEALTH INC | 15 Oct 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TERBINAFINE (100) | SIVEM PHARMACEUTICALS ULC | 14 Dec 2024 | 15 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TERBINAFINE (30) | SIVEM PHARMACEUTICALS ULC | 14 Dec 2024 | 15 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | LAMISIL (2 X 14) discontinuation | NOVARTIS PHARMACEUTICALS CANADA INC | not given | not given | Not stated |
| IT | TERBINAFINA EG | EG S.P.A. | 31 Aug 2026 | not given | Increased demand Elevata richiesta |
| IT | TERBINAFINA AUROBINDO PHARMA ITALIA | AUROBINDO PHARMA (ITALIA) S.R.L. | 16 Sep 2026 | not given | Regulatory or licensing Problemi regolatori |
| IT | TERBINAFINA TECNIGEN anticipated | TECNIGEN S.R.L. | 15 Dec 2026 | not given | Manufacturing problem Problemi produttivi |
| BE | Terbinafine Viatris 250 mg tabl. 14 | Viatris GX | 7 Aug 2026 | 3 Dec 2026 | Increased demand |
| BE | Terbinafine Viatris 250 mg tabl. 56 | Viatris GX | 17 Aug 2026 | 3 Dec 2026 | Increased demand |
| BE | Terbinafin AB 250 mg tabl. 56 | Aurobindo | 26 Aug 2026 | 13 Nov 2026 | Other Other reason |
| BE | Terbinafine Sandoz 250 mg tabl. 56 | Sandoz | 28 Sep 2026 | 27 Nov 2026 | Manufacturing problem Delay in production |
| BE | Terbinafine Sandoz 250 mg tabl. 98 | Sandoz | 28 Sep 2026 | 27 Nov 2026 | Manufacturing problem Delay in production |
| BE | Terbinafin AB 250 mg tabl. 14 | Aurobindo | 23 Oct 2026 | 15 Nov 2026 | Other Other reason |
| BE | Terbinafin AB 250 mg tabl. 98 | Aurobindo | 23 Oct 2026 | 15 Nov 2026 | Other Other reason |
| CZ | TERFIMED 250MG 250MG TBL NOB 14 II anticipated | PRO.MED.CS Praha a.s. | 1 Jan 2027 | 19 Apr 2027 | Manufacturing problem Výrobní důvody |
| JP | テルビナフィン塩酸塩クリーム1%「サワイ」 limited | Sawai | 8 Jul 2025 | not given | Manufacturing problem |
| JP | テルビナフィン塩酸塩クリーム1%「JG」 limited | Nihon Generic | 25 Jul 2025 | not given | Increased demand |
| JP | ラミシールクリーム1% limited | Sun Pharma | 21 Oct 2025 | not given | Increased demand |
| JP | テルビナフィン塩酸塩クリーム1%「イワキ」 limited | 岩城製薬 | 13 May 2026 | not given | Manufacturing problem |
| JP | テルビナフィン塩酸塩クリーム1%「トーワ」 limited | Towa (Pensa) | 16 Jul 2026 | not given | Increased demand |
| JP | テルビナフィン錠125mg「サワイ」 limited | Sawai | 30 Jul 2026 | not given | Manufacturing problem |
| JP | テルビナフィン塩酸塩錠125mg「フェルゼン」 | フェルゼンファーマ | 21 Aug 2026 | not given | Other |
| JP | テルビナフィン錠125mg「タカタ」 limited | Takata Pharmaceutical | 26 Aug 2026 | 28 Nov 2026 | Other |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Terbinafine shortage?
Yes. As of 4 Nov 2026, Terbinafine is reported short in 5 of the 16 countries we track: Canada, Italy, Belgium, Czechia, Japan. The earliest expected return is 13 Nov 2026 (Belgium). 15 of 26 affected products have no return date. New since 5 Oct 2026: Belgium.
When will Terbinafine be back in stock?
Companies expect supply back from 13 Nov 2026 in Belgium; Canada: 15 Dec 2026; Italy: no date given; Belgium: 13 Nov 2026; Czechia: 19 Apr 2027; Japan: 28 Nov 2026. These are company estimates reported to each authority.
Why is Terbinafine in short supply?
The most common reason reported is: manufacturing problem. Reasons by product are listed in the table below.
Which companies have Terbinafine shortages?
Aurobindo, Jamp, Sivem, Viatris, Sandoz, Sawai, Teva, Sanis, Novartis, Stada.